unknown
Stage
About
GLX Analytix develops a clinical-stage blood test platform that measures glycocalyx sugar structures in blood to diagnose and monitor neuropsychiatric, neurodegenerative, and autoimmune brain diseases using AI-driven biomarker signatures.
Explore GLX Analytix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.